Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment  Javier Domingo, M.D., Vicente.

Slides:



Advertisements
Similar presentations
Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles  Ryan G. Steward,
Advertisements

Lynn B. Davis, M. D. , M. S. , Sara J. Champion, M. S. , Steve O
Elias M. Dahdouh, M. D. , M. Sc. , Jacques Balayla, M. D
Study of nucleation status in the second cell cycle of human embryo and its impact on implantation rate  Jesus Aguilar, Ph.D., Irene Rubio, Ph.D., Elkin.
Male infertility: a biomarker of individual and familial cancer risk
Lynn B. Davis, M. D. , M. S. , Sara J. Champion, M. S. , Steve O
Age at menarche: a predictor of diminished ovarian function?
Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates  Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.
Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization.
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial  Juan.
José Bellver, M. D. , Marco A. B. Melo, M. D. , Ernesto Bosch, M. D
Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase  Michael von Wolff, M.D., Christian J. Thaler,
Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience  Kutluk Oktay, M.D.,
Michael M. Alper, M.D.  Fertility and Sterility 
Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis  Laura Prieto, M.D., Juan F. Quesada,
Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients  Alberta Fabris, M.D., Alberto Pacheco,
Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials  Ana Cobo, Ph.D., César Diaz, M.D. 
Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer 
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Inmaculada Molina, Ph. D. , Juan V. Martínez, M. S. , José F
Medical treatment of ectopic pregnancy: a committee opinion
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers  Andrea.
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes  Jin-Ho Lim, M.D., Seong-Ho Yang,
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Oocyte cryopreservation
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to.
Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis  Laura P. Smith, M.D.,
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Male infertility: a biomarker of individual and familial cancer risk
Clomiphene citrate at 50: the dawning of assisted reproduction
Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors  José Bellver, M.D., Antonio.
Ana Cobo, Ph. D. , Juan A. García-Velasco, M. D. , Aila Coello, Ph. D
Treatment of Ovarian Hyperstimulation Syndrome Utilizing a Dopamine Agonist and Gonadotropin Releasing Hormone antagonist  N. Rollene, M. Amols, S. Hudson,
Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic.
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Cumulative newborn rates increase with the total number of transferred embryos according to an analysis of 15,792 ovum donation cycles  Nicolás Garrido,
Thomas M. D’Hooghe, M. D. , Ph. D. , Bénédicte Denys, M. D
Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,
Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis 
Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D. 
José Bellver, M. D. , Yanira Ayllón, M. D. , Marcos Ferrando, M. D
Zsolt P. Nagy, M. D. , Ph. D. , Laura F. Rienzi, Ph. D. , Filippo M
Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series  Nanette L. Rollene,
Roberto Ensenat-Waser, Ph. D. , Antonio Pellicer, M. D. , Ph. D
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing 
María A. Higón, M. D. , Santiago Domingo, M. D. , Celia Bauset, M. D
Fertility and Sterility: an evaluation
Sedigheh Borna, M.D., Azita Nasery, M.D.  Fertility and Sterility 
Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis  Ernesto Bosch, M.D., Elena.
Current evaluation of amenorrhea
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
The J-Tip Needle-Free Injection System in controlled ovarian hyperstimulation in in vitro fertilization: a pilot study  Stuart A. Lavery, M.R.C.O.G.,
Combined use of uterine artery embolization and local methotrexate injection in interstitial ectopic pregnancies with poor prognosis  Gemma Tamarit, M.D.,
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
In vitro sildenafil citrate use as a sperm motility stimulant
Bárbara Oriol, M. D. , Ana Barrio, M. D. , Alberto Pacheco, Ph. D
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Ongoing pregnancy rates in intrauterine insemination are affected by late follicular- phase progesterone levels  Antonio Requena, M.D., María Cruz, Ph.D.,
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing.
P-24 Fertility and Sterility Volume 85, Pages S19-S20 (April 2006)
In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study  Carmen Rubio,
Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment  Daniel Bodri, M.D., M.Sc.,
Presentation transcript:

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment  Javier Domingo, M.D., Vicente Guillén, M.D., Yanira Ayllón, M.D., María Martínez, M.D., Elkin Muñoz, M.D., Antonio Pellicer, M.D., Juan A. Garcia-Velasco, M.D.  Fertility and Sterility  Volume 97, Issue 4, Pages 930-934 (April 2012) DOI: 10.1016/j.fertnstert.2012.01.093 Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Schematic representation of the protocols used in the three groups of patients. Fertility and Sterility 2012 97, 930-934DOI: (10.1016/j.fertnstert.2012.01.093) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Mean number of retrieved oocytes stratified by patient’s age. Fertility and Sterility 2012 97, 930-934DOI: (10.1016/j.fertnstert.2012.01.093) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.